1397228-36-2

Upstream product

• 695-34-1 2-Amino-4-methylpyridine 

Downstream Products

• 1426653-21-5 N-(2-fluoro-5-(((1S,2S)-1-hydroxy-3-methoxy-1-phenylpropan-2-yl)carbamoyl)phenyl)-7-methylimidazo[1,2-a]pyridine-3-carboxamide 
• 1426653-22-6 N-(5-(((1S,2S)-1,3-dihydroxy-1-phenylpropan-2-yl)carbamoyl)-2-fluorophenyl)-7-methylimidazo[1,2-a]pyridine-3-carboxamide 
• 21801-80-9 7-methylimidazo[1,2-a]pyridine-3-carboxylic acid 
• 1426654-02-5 4-fluoro-3-(7-methylimidazo[1,2-a]pyridine-3-carboxamido)benzoic acid 
• 1426654-03-6 methyl 4-fluoro-3-(7-methylimidazo[1,2-a]pyridine-3-carboxamido)benzoate 

Relevant academic research and scientific papers

IMIDAZO-CONDENSED BICYCLES AS INHIBITORS OF DISCOIDIN DOMAIN RECEPTORS (DDRS)

The invention provides a compound of formula (I) (Formula (I)) or a tautomeric form, stereochemically isomeric form, N-oxide, pharmaceutically acceptable salt or solvate thereof, wherein R2, R3, R4, Ra, Rb

COMPOUNDS AND COMPOSITIONS AS PDGFR KINASE INHIBITORS

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase